A single infusion edited liver cells to slash LDL and triglycerides for 3 years in primates
Gene editing had a big week — and not just in the lab.
From a human liver biopsy confirming a successful base edit to a three-year primate study on cholesterol, the distance between bench and bedside got a little shorter.
One shot, three years of lower cholesterol 🧬
- Researchers delivered a CRISPR adenine base editor — packaged in a lipid nanoparticle and aimed at a gene called ANGPTL3 — via a single intravenous infusion in nonhuman primates. The result: circulating ANGPTL3 protein dropped by more than 90%, and the reduction held for the full 3-year observation window.
- In primate and mouse models of high cholesterol, that gene inactivation was associated with roughly 40–50% lower LDL cholesterol and 50–70% lower triglycerides — both major drivers of cardiovascular disease.
- Critically, researchers screened approximately 3,000 candidate off-target sites in human liver cells and found no detectable off-target edits and no structural variants.
Why it matters: Most cholesterol drugs require daily or monthly dosing for life. A one-time infusion with durable, liver-specific effects — and a clean safety profile so far — is a meaningfully different proposition. A first-in-human trial in patients with refractory high-lipid conditions is now underway.
Key Findings
A liver biopsy confirmed base editing actually worked in a human 🔬
- A patient with alpha-1 antitrypsin deficiency — a genetic liver and lung disease caused by a single mutation — received in vivo base editing therapy, and a subsequent liver biopsy directly confirmed that the target gene was corrected at the hepatic level.
- This is the first reported clinical case where liver tissue was sampled post-treatment to verify the edit, moving beyond blood biomarkers alone.
A muscle-targeted virus fixed dystrophy in mice — while skipping the liver 🐭
- Using a compact base editor packed into a single AAV vector with a muscle-tropic capsid called MyoAAV4, researchers restored dystrophin protein in the hearts and skeletal muscles of mice modeling Duchenne muscular dystrophy at a lower dose than conventional approaches.
- A liver-detargeted capsid variant (MyoAAV4E-off) eliminated viral entry and editing in the liver entirely — addressing one of the field's persistent safety concerns around high-dose AAV.
Chromatin packaging affects base editors and prime editors very differently
- In human cells, tightly packed heterochromatin — the "closed" regions of the genome — mostly blocked prime editors but left base editors unhindered, and in some cases base editors were actually more active in heterochromatin than in open chromatin regions.
- The type and extent of editing byproducts from base editing also shifted depending on the epigenetic context of the target sequence, which has direct implications for how editing safety is assessed.
Prime editing stacked multiple disease-resistance traits in tomato in one generation 🍅
- Using three optimized prime editors, researchers precisely recreated a pepper-derived disease-resistance deletion in tomato and separately introduced mutations that conferred resistance to two different bacterial pathogens — Xanthomonas and Pseudomonas syringae.
- A multiplex prime editing system combined these resistance alleles within a single generation, and the traits were stably inherited and maintained under elevated temperature conditions.
Supercharging NK cells with CRISPR may help clear HIV reservoirs
- Using a CRISPR activation approach — which turns genes up rather than cutting them out — researchers simultaneously boosted expression of IL-15 and its receptor in primary natural killer cells without altering the underlying DNA sequence.
- In lab co-culture experiments with HIV-positive T-cell lines, these enhanced NK cells showed increased target cell elimination and higher secretion of an immune-signaling protein compared to unmodified cells.
A $3 sealed-tube test detected two STIs from whole blood in 30 minutes 💉
- A microfluidic chip integrating recombinase amplification, light-triggered CRISPR activation, and dual fluorescence readout simultaneously detected HIV and syphilis-causing bacteria directly from whole blood, with no external lab equipment needed.
- In 51 clinical samples, the fluorescence readout hit 100% sensitivity and specificity; per-reaction reagent cost was estimated at USD 3.21 using bulk-purchased components.
Implications
Base editing is quietly moving from animal models into human tissue confirmation — a shift that changes what counts as evidence. The open question: whether the clean off-target profiles seen in controlled primate and cell-line studies will hold across the genetic diversity of real patient populations at scale.
Studies in this issue
Primary sources used for this newsletter.
- Using Gene Editing in Living Organisms to Lower Blood Fat Levels by Targeting ANGPTL3main storyNature2026-11-06PMID 42994815
- Liver biopsy shows accurate and effective correction of SERPINA1 gene by base editing in a patient with Alpha-1 Antitrypsin Deficiencykey findingJournal of hepatology2026-11-02PMID 42971508
- A single muscle-targeting gene therapy that avoids the liver improves muscular dystrophy in human-like mice using precise gene editingkey findingThe Journal of clinical investigation2026-11-02PMID 42969232
- How DNA packaging affects the accuracy and consistency of prime and base gene editorskey findingMolecular cell2026-11-03PMID 42976864
- Boosting natural killer cells to fight HIV-infected cells using IL-15 and its receptor activationkey findingJournal of leukocyte biology2026-11-05PMID 42987219
- Single-step CRISPR test for detecting HIV and syphilis directly from whole blood at the point of carekey findingACS sensors2026-11-04PMID 42981222
- Precise addition of multiple disease-resistance genes in tomato using improved gene editingkey findingThe Plant cell2026-11-05PMID 42987176
Continue reading
All CRISPR Gene Editing issuesGet the next CRISPR Gene Editing issue
Seven papers, once a week. Free.